Skip to main content

Want a detailed portfolio tracker?

Adaptive Biotechnologies (ADPT) Earnings (2018 - 2026)

Adaptive Biotechnologies (ADPT) earnings from Jun 30, 2018 to Mar 31, 2026. The TTM Adaptive Biotechnologies (ADPT) earnings is -$50M. You can adjust inflation or export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

Annual Earnings

Quarterly Earnings

Adaptive Biotechnologies (ADPT) Earnings CAGR table

PeriodCAGR
1 Year TTM-64.98%
3 Years TTM-36.63%
5 Years TTM-20.40%
All Time TTM+2.39%

Annual Earnings change of Adaptive Biotechnologies (ADPT)

YearEarningsChange
2026-$20M-66.34%
2025-$60M-62.69%
2024-$159M-29.19%
2023-$225M+12.52%
2022-$200M-3.42%
2021-$207M+41.75%
2020-$146M+113.13%
2019-$69M+47.71%
2018-$46M+8.45%
2017-$43MN/A

Comparison Adaptive Biotechnologies (ADPT) five years earnings CAGR with competitors

Adaptive Biotechnologies (ADPT) five years earnings CAGR is -20.40%.

TickerNamefive years Earnings CAGRUpside
NOTVInotiv, Inc. Common Stock105.11%-615.21%
PRPHProPhase Labs Inc91.63%-549.13%
IQVIQVIA Holdings Inc27.63%-235.43%
MEDPMedpace Holdings Inc23.58%-215.58%
ISPCiSpecimen Inc17.65%-186.53%
PSNLPersonalis Inc16.49%-180.83%
BNRBurning Rock Biotech Ltd15.43%-175.63%
WATWaters Corp15.32%-175.08%
IMDXInsight Molecular Diagnostics Inc12.87%-163.07%
IDXXIdexx Laboratories Inc10.19%-149.95%
AAgilent Technologies Inc8.86%-143.42%
MTDMettler-Toledo International Inc8.29%-140.63%
MYNZMainz Biomed N.V.6.76%-133.12%
ILMNIllumina Inc6.25%-130.63%
GHGuardant Health Inc6.12%-130.02%
MDXHMDxHealth SA4.58%-122.43%
XGNExagen Inc3.92%-119.20%
QGENQiagen NV3.42%-116.75%